Sichuan Goldstone Stock Hits Day Low of CNY 10.91 Amid Price Pressure

Sichuan Goldstone Asia Pharmaceutical, Inc. experienced a notable decline today, with its stock price dropping by 7.62% on July 17, 2026. The stock reached an intraday low of CNY 10.91, reflecting a challenging trading session for the small-cap company. In terms of performance metrics, Sichuan Goldstone has shown a mixed trajectory over various time frames. Over the past week, the stock has decreased by 8.78%, while its one-month performance remains positive at 22.17%. Year-to-date, the stock has gained 6.13%, contrasting with the broader China Shanghai Composite, which has seen a decline of 5.16% during the same period. Despite the recent downturn, the company has reported significant growth in net profit, with a remarkable increase of 232.83% in its latest quarterly results. The return on equity stands at 6.61%, and the price-to-book ratio is an attractive 0.68. Additionally, the company has maintained a high dividend yield of 0.76%, indicating a commitment to returning value to shareholders.